BeiGene
BGNE
#916
Rank
S$29.30 B
Marketcap
$261.78
Share price
0.15%
Change (1 day)
5.82%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company